Big focus on heart health outcome trials with PIONEER 6 and CAROLINA in the spotlight; plus promising CGM data in adolescents with type 1 diabetes
Diabetes Drug News
Diabetes Drugs are responsible for helping to decrease blood sugar levels so that you can try to stay in a healthier range and help avoid serious complications.
Metformin Insulin SGLT-2 GLP-1 DPP-4 Combo drugs Sulfonylureas TZDs
25 readers recommended
Zynquista was not approved by the FDA; Complete Response Letter suggests the FDA is weighing safety concerns of the SGLT-1/2 dual inhibitor for type 1 diabetes
34 readers recommended
A new guidance document from the American Diabetes Association (ADA) and European Association for the Study of Diabetes (EASD) calls for more patient-centered care and...
Possible Breakthrough for Type 2s: The First GLP-1 Pill Is Submitted for Approval to the FDA and EMA
79 readers recommended
The first GLP-1 pill for type 2 diabetes offers weight loss and A1C reduction without injections; US decision expected in September 2019, EU decision expected spring of...
34 readers recommended
FDA updates Invokana label – the type 2 diabetes therapy now improves heart health in type 2’s with established heart disease in addition to glucose lowering
39 readers recommended
If approved, Lilly’s intranasal glucagon would be a radical ease-of-use improvement over current glucagon kits for severe hypoglycemia
29 readers recommended
The benefits of measuring time in range, plus new care guidelines for adults with type 2 diabetes
32 readers recommended
A once-daily pill combining metformin, Farxiga, and Onglyza helps lower A1C and support weight loss
28 readers recommended
FlowSmart infusion set officially discontinued. On the plus side, BD plans to launch a tubeless type 2 diabetes insulin patch pump starting in late 2019.
34 readers recommended
A huge milestone that makes Forxiga the first pill for people with type 1 diabetes in Europe
49 readers recommended
A study recruiting 10,000 people will look at whether Zynquista (sotagliflozin) has effects beyond glucose-lowering and weight loss
37 readers recommended
Zealand Pharma shared positive trial results for its dasiglucagon – 99% of participants recovered from hypo within 15 minutes of treatment
48 readers recommended
A recent study found 38% of those with type 1 diagnosed after age 30 were not initially given insulin; learn ways of differentiating between type 1 and type 2 at...
46 readers recommended
The latest on Dexcom’s work with Verily to make a more simple and accessible CGM; also, the “Pro Q” professional CGM and insulin dosing advice for people on multiple...
42 readers recommended
Results from the CREDENCE trial suggest that Invokana’s kidney benefits exist on top of blood pressure lowering medications (standard of care)
45 readers recommended
Xeris’ Glucagon Rescue Pen, designed as an auto-injector, features a ready-to-use liquid glucagon – a safer and more convenient treatment option for severe hypoglycemia
33 readers recommended
Insightful diabetes leaders discuss high-potential areas ranging from SGLT-2s in type 1 diabetes, personalized treatment plans, and the do-it-yourself Loop app
68 readers recommended
Amarin’s Vascepa, an omega-3 fatty acid, is shown to lower risk of heart attack, stroke, and heart-related death for adults with high risk for heart disease with...
82 readers recommended
SGLT-2 inhibitors and GLP-1 agonists recommended as first-line therapies; Farxiga offers heart health benefits in people with and without diabetes
48 readers recommended
Farxiga becomes the first SGLT-2 inhibitor drug approved to reduce the risk of hospitalization for heart failure in adults who have type 2 diabetes and heart disease or...